Exagen (XGN) Short Interest Ratio & Short Volume $4.00 -0.10 (-2.44%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$4.09 +0.09 (+2.28%) As of 01/31/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exagen Short Interest DataExagen (XGN) has a short interest of 7,400 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a -90.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 189,508 shares to cover all short positions.Current Short Interest7,400 sharesPrevious Short Interest79,200 sharesChange Vs. Previous Month-90.66%Dollar Volume Sold Short$23,088.00Short Interest Ratio0.1 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares17,640,000 sharesFloat Size8,800,000 sharesShort Percent of Float0.08%Today's Trading Volume74,310 sharesAverage Trading Volume189,508 sharesToday's Volume Vs. Average39% Short Selling Exagen? Sign up to receive the latest short interest report for Exagen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXGN Short Interest Over TimeXGN Days to Cover Over TimeXGN Percentage of Float Shorted Over Time Exagen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20257,400 shares $23,088.00 -90.7%0.1%0.1 $3.12 12/31/202479,200 shares $324,720.00 +1.4%0.9%0.7 $4.10 12/15/202478,100 shares $451,027.50 +36.5%0.9%1 $5.78 11/30/202457,200 shares $227,084.00 -9.1%0.7%1.2 $3.97 11/15/202462,900 shares $187,442.00 +20.5%0.8%1.4 $2.98 10/31/202452,200 shares $126,846.00 +122.1%0.6%1.4 $2.43 10/15/202423,500 shares $63,450.00 +48.7%0.3%0.4 $2.70 9/30/202415,800 shares $48,822.00 -6.0%0.2%0.3 $3.09 9/15/202416,800 shares $49,728.00 +20.9%0.2%0.3 $2.96 8/31/202413,900 shares $41,422.00 -12.0%0.2%0.3 $2.98 Get the Latest News and Ratings for XGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exagen and its competitors with MarketBeat's FREE daily newsletter. 8/15/202415,800 shares $44,714.00 -41.5%0.2%0.3 $2.83 7/31/202427,000 shares $52,650.00 -7.2%0.3%0.5 $1.95 7/15/202429,100 shares $57,618.00 -22.2%0.3%0.8 $1.98 6/30/202437,400 shares $68,068.00 +67.7%0.4%1.1 $1.82 6/15/202422,300 shares $43,708.00 -7.5%0.3%0.6 $1.96 5/31/202424,100 shares $46,995.00 -14.8%0.3%0.5 $1.95 5/15/202428,300 shares $54,053.00 +573.8%0.3%0.6 $1.91 4/30/20244,200 shares $5,754.00 -64.7%0.1%0.1 $1.37 4/15/202411,900 shares $17,017.00 -42.0%0.2%0.3 $1.43 3/31/202420,500 shares $32,595.00 +294.2%0.3%0.5 $1.59 3/15/20245,200 shares $8,424.00 +20.9%0.1%0.1 $1.62 2/29/20244,300 shares $9,675.00 -35.8%0.1%0.1 $2.25 2/15/20246,700 shares $14,137.00 -39.1%0.1%0.1 $2.11 1/31/202411,000 shares $23,650.00 +32.5%0.1%0.2 $2.15 1/15/20248,300 shares $16,600.00 -65.7%0.1%0.2 $2.00 12/31/202324,200 shares $48,158.00 +633.3%0.3%0.5 $1.99 12/15/20233,300 shares $5,115.00 -65.6%0.0%0.1 $1.55 11/30/20239,600 shares $18,048.00 +28.0%0.1%0.3 $1.88 11/15/20237,500 shares $11,586.00 +4.2%0.1%0.4 $1.54 10/31/20237,200 shares $11,808.00 +24.1%0.1%0.6 $1.64 10/15/20235,800 shares $10,904.00 -45.3%0.1%0.4 $1.88 9/30/202310,600 shares $25,652.00 -14.5%0.1%0.7 $2.42 9/15/202312,400 shares $30,132.00 +27.8%0.2%0.8 $2.43 8/31/20239,700 shares $24,444.00 -17.8%0.1%0.6 $2.52 8/15/202311,800 shares $29,500.00 +81.5%0.1%0.8 $2.50 7/31/20236,500 shares $15,990.00 -38.7%0.1%0.3 $2.46 7/15/202310,600 shares $28,620.00 +39.5%0.1%0.6 $2.70 6/30/20237,600 shares $22,040.00 +8.6%0.1%0.5 $2.90 6/15/20237,000 shares $22,540.00 -42.2%0.1%0.4 $3.22 5/31/202312,100 shares $36,421.00 +72.9%0.1%0.6 $3.01He called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next. (Ad)With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … 5/15/20237,000 shares $20,370.00 -54.6%0.1%0.3 $2.91 4/30/202315,400 shares $39,116.00 +75.0%0.2%0.9 $2.54 4/15/20238,800 shares $21,384.00 +8.6%0.1%0.5 $2.43 3/31/20238,100 shares $19,683.00 -16.5%0.1%0.4 $2.43 3/15/20239,700 shares $22,989.00 -54.9%0.1%0.4 $2.37 2/28/202321,500 shares $54,825.00 +32.7%0.2%0.8 $2.55 2/15/202316,200 shares $40,824.00 -22.1%0.2%0.3 $2.52 1/31/202320,800 shares $59,072.00 -64.0%0.2%0.2 $2.84 1/15/202357,800 shares $167,042.00 -20.4%0.6%0.6 $2.89 12/30/202272,600 shares $174,240.00 -30.1%0.7%0.8 $2.40 12/15/2022103,900 shares $257,672.00 +3.5%1.1%1.1 $2.48 11/30/2022100,400 shares $271,080.00 +666.4%1.0%1.1 $2.70 11/15/202213,100 shares $39,169.00 -34.8%0.1%0.2 $2.99 10/31/202220,100 shares $49,245.00 -33.7%0.2%0.7 $2.45 10/15/202230,300 shares $73,629.00 -14.2%0.3%1.6 $2.43 9/30/202235,300 shares $95,663.00 +18.5%0.4%1.6 $2.71 9/15/202229,800 shares $141,252.00 -18.4%0.3%0.7 $4.74 8/31/202236,500 shares $165,345.00 -5.7%0.4%0.8 $4.53 8/15/202238,700 shares $195,435.00 -14.8%0.4%0.7 $5.05 7/31/202245,400 shares $335,506.00 -25.2%0.5%0.8 $7.39 7/15/202260,700 shares $449,180.00 -23.7%0.7%0.9 $7.40 6/30/202279,600 shares $456,904.00 -79.5%0.9%1.2 $5.74 6/15/2022387,600 shares $2.37 million -4.1%4.2%6 $6.12 5/31/2022404,100 shares $2.02 million +5.0%4.4%8.6 $5.00 5/15/2022384,800 shares $1.86 million +9.6%4.2%8.6 $4.83 4/30/2022351,000 shares $2.14 million +73.3%3.8%8.6 $6.10 4/15/2022202,600 shares $1.28 million +0.5%2.2%5.7 $6.31 3/31/2022201,700 shares $1.62 million +23.4%2.2%5.9 $8.03 3/15/2022163,400 shares $1.30 million +16.8%1.8%5.2 $7.98 2/28/2022139,900 shares $1.06 million +18.1%1.5%3.9 $7.60 2/15/2022118,500 shares $1.03 million +21.8%1.3%3.3 $8.65 1/31/202297,300 shares $956,459.00 +49.0%1.1%2.7 $9.83 1/15/202265,300 shares $593,577.00 -2.1%0.7%1.8 $9.09 12/31/202166,700 shares $775,721.00 -0.3%0.8%1.9 $11.63 12/15/202166,900 shares $602,100.00 -21.9%0.8%2.1 $9.00 11/30/202185,700 shares $880,996.00 -1.7%0.9%2 $10.28 11/15/202187,200 shares $1.11 million -77.7%0.9%1.9 $12.68 10/29/2021390,900 shares $4.54 million -1.7%4.2%6.2 $11.62 10/15/2021397,600 shares $5.02 million -4.7%4.3%6.3 $12.63 9/30/2021417,000 shares $5.67 million -0.9%4.5%6.2 $13.60 9/15/2021420,800 shares $5.84 million -4.9%4.5%5 $13.87 8/31/2021442,400 shares $6.24 million +3.5%4.6%5.7 $14.10 8/13/2021427,600 shares $5.25 million -1.0%4.5%5.8 $12.28 7/30/2021431,800 shares $5.15 million +0.5%4.3%6.2 $11.92 7/15/2021429,800 shares $5.98 million -4.7%4.3%7 $13.92 6/30/2021451,000 shares $6.76 million +23.0%4.5%6.2 $14.99 6/15/2021366,600 shares $6.14 million +0.2%3.7%5.3 $16.75 5/28/2021365,800 shares $5.21 million +5.0%3.6%4.8 $14.25 5/14/2021348,400 shares $4.32 million +51.1%3.5%4.5 $12.40 4/30/2021230,600 shares $3.87 million +1.9%3.0%3.1 $16.80He called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next. (Ad)With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … 4/15/2021226,400 shares $3.78 million +139.3%3.1%3.3 $16.69 3/31/202194,600 shares $1.65 million -12.6%1.4%1.6 $17.42 3/15/2021108,200 shares $2.17 million -15.3%2.0%2.2 $20.02 2/26/2021127,700 shares $2.46 million +4.1%2.4%3.9 $19.24 2/12/2021122,700 shares $2.25 million +12.1%2.3%4.5 $18.35 1/29/2021109,500 shares $1.78 million -4.7%2.1%4.1 $16.28 1/15/2021114,900 shares $1.69 million -3.2%2.2%5 $14.68 12/31/2020118,700 shares $1.43 million -13.1%2.3%6.3 $12.08 12/15/2020136,600 shares $1.76 million +10.2%2.7%10.9 $12.90 11/30/2020124,000 shares $1.83 million -2.7%2.5%11.8 $14.75 10/30/2020140,200 shares $2.03 million -1.7%2.8%7.4 $14.49 10/15/2020142,600 shares $2.12 million +1.3%2.9%5.7 $14.89 XGN Short Interest - Frequently Asked Questions What is Exagen's current short interest? Short interest is the volume of Exagen shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 7,400 shares of XGN short. 0.08% of Exagen's shares are currently sold short. Learn More on Exagen's current short interest. What is a good short interest percentage for Exagen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Exagen's floating shares are currently sold short. Is Exagen's short interest increasing or decreasing? Exagen saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 7,400 shares, a drop of 90.7% from the previous total of 79,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exagen's float size? Exagen currently has issued a total of 17,640,000 shares. Some of Exagen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exagen currently has a public float of 8,800,000 shares. How does Exagen's short interest compare to its competitors? 0.08% of Exagen's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Exagen: AirSculpt Technologies, Inc. (24.04%), LifeMD, Inc. (13.48%), Sera Prognostics, Inc. (3.95%), Biodesix, Inc. (0.52%), Quipt Home Medical Corp. (4.09%), EUDA Health Holdings Limited (0.04%), P3 Health Partners Inc. (4.79%), Burning Rock Biotech Limited (0.70%), The Oncology Institute, Inc. (0.95%), Enzo Biochem, Inc. (0.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Exagen stock? Short selling XGN is an investing strategy that aims to generate trading profit from Exagen as its price is falling. XGN shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exagen? A short squeeze for Exagen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XGN, which in turn drives the price of the stock up even further. How often is Exagen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XGN, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies AirSculpt Technologies Short Interest LifeMD Short Interest Sera Prognostics Short Interest Biodesix Short Interest Quipt Home Medical Short Interest EUDA Health Short Interest P3 Health Partners Short Interest Burning Rock Biotech Short Interest Oncology Institute Short Interest Enzo Biochem Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XGN) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XGN Stock Alerts